Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Colleen A. McHorney, Eric D. Peterson, Veronica Ashton, François Laliberté, Concetta Crivera, Guillaume Germain, Naveed Sheikh, Jeff Schein & Patrick Lefebvre. (2019) Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients. Current Medical Research and Opinion 35:4, pages 653-660.
Read now
Read now
DF van Breukelen-van der Stoep, J Zijlmans, D van Zeben, B Klop, GJM van de Geijn, N van der Meulen, M Hazes, E Birnie & M Castro Cabezas. (2015) Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 44:6, pages 443-448.
Read now
Read now
Stephanie Chen, Elyse Swallow, Nanxin Li, Elizabeth Faust, Caroline Kelley, Jipan Xie & Eric Wu. (2015) Economic benefits associated with beta blocker persistence in the treatment of hypertension: a retrospective database analysis. Current Medical Research and Opinion 31:4, pages 615-622.
Read now
Read now
Samir G Mallat, Houssam S Itani & Bassem Y Tanios. (2013) Current perspectives on combination therapy in the management of hypertension. Integrated Blood Pressure Control 6, pages 69-78.
Read now
Read now
James E. Signorovitch, Thomas M. Samuelson, Karthik Ramakrishnan, Maryna Marynchenko, Eric Q. Wu, Steven I. Blum, Abhilasha Ramasamy & Stephanie Chen. (2012) Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis. Current Medical Research and Opinion 28:4, pages 591-599.
Read now
Read now
Oliver Bruder, Christoph J. Jensen, Michael Bell, Reinhard Rummel, Guenter Boehm, Sven Klebs, Christian Sieder & Jochen Senges. (2012) Effects of the combinations of amlodipine/valsartan versus losartan/hydrochlorothiazide on left ventricular hypertrophy as determined with magnetic resonance imaging in patients with hypertension. Journal of Drug Assessment 1:1, pages 1-10.
Read now
Read now
Luca Degli Esposti, Stefania Saragoni, Silvia Benemei, Paolo Batacchi, Pierangelo Geppetti, Mauro Di Bari, Niccolò Marchionni, Alessandra Sturani, Stefano Buda & Ezio Degli Esposti. (2011) Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. ClinicoEconomics and Outcomes Research 3, pages 47-54.
Read now
Read now
Luca Degli Esposti, Stefania Saragoni, Paolo Batacchi, Pierangelo Geppetti, Stefano Buda & Ezio Degli Esposti. (2010) Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years. ClinicoEconomics and Outcomes Research 2, pages 113-120.
Read now
Read now
Vivencio Barrios & Carlos Escobar. (2010) Valsartan–amlodipine–hydrochlorothiazide: the definitive fixed combination?. Expert Review of Cardiovascular Therapy 8:11, pages 1609-1618.
Read now
Read now
Ji-Guang Wang. (2009) A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention. Vascular Health and Risk Management 5, pages 593-605.
Read now
Read now
N. Braun, H.-J. Ulmer, A. Ansari, R. Handrock & S. Klebs. (2009) Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination. Current Medical Research and Opinion 25:2, pages 421-430.
Read now
Read now
Colleen A. McHorney. (2009) The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Current Medical Research and Opinion 25:1, pages 215-238.
Read now
Read now
Articles from other publishers (55)
Juliana de Oliveira Costa, Jialing Lin, Sallie‐Anne Pearson, Nicholas A. Buckley, Andrea L. Schaffer & Michael O. Falster. (2023) Persistence and Adherence to Cardiovascular Medicines in Australia. Journal of the American Heart Association 12:13.
Crossref
Crossref
Vicente F. Gil-Guillen, Alejandro Balsa, Beatriz Bernárdez, Carmen Valdés y Llorca, Emilio Márquez-Contreras, Juan de la Haba-Rodríguez, Jose M. Castellano & Jesús Gómez-Martínez. (2022) Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions. International Journal of Environmental Research and Public Health 19:19, pages 12036.
Crossref
Crossref
Tamás Ágh, Maja Ortner Hadžiabdić, Kristina Garuoliene, Anne Gerd Granas, Emma Aarnio, Enrica Menditto, João Gregório, Pilar Barnestein-Fonseca, Vildan Mevsim & Przemysław Kardas. (2022) Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study. Frontiers in Pharmacology 13.
Crossref
Crossref
Y Feng, Y Zhao, X Yang, Y Li, M Han, R Qie, S Huang, X Wu, Y Zhang, Y Wu, D Liu, D Zhang, C Cheng, F Hu, M Zhang, Y Yang, X Shi, L Sun & Dongsheng Hu. (2022) Adherence to antihypertensive medication and cardiovascular disease events in hypertensive patients: a dose–response meta-analysis of 2 769 700 participants in cohort study. QJM: An International Journal of Medicine 115:5, pages 279-286.
Crossref
Crossref
Qi Lu, Yanbo Zhang, Tingting Geng, Kun Yang, Kunquan Guo, Xinwen Min, Meian He, Huan Guo, Xiaomin Zhang, Handong Yang, Tangchun Wu, An Pan & Gang Liu. (2022) Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China. JAMA Network Open 5:2, pages e2146118.
Crossref
Crossref
Aikaterini Kassavou, Charlotte A. Court, Venus Mirzaei, James Brimicombe, Simon Edwards & Stephen Sutton. (2021) Process Evaluation of MAPS: A Highly Tailored Digital Intervention to Support Medication Adherence in Primary Care Setting. Frontiers in Public Health 9.
Crossref
Crossref
Anjana Mohan, Aisha Vadhariya, Zahra Majd, Tara W Esse, Omar Serna & Susan M. Abughosh. (2021) Impact of a motivational interviewing intervention targeting statins on adherence to concurrent hypertension or diabetes medications. Patient Education and Counseling 104:7, pages 1756-1764.
Crossref
Crossref
Aikaterini Kassavou, Venus Mirzaei, Sonia Shpendi, James Brimicombe, Jagmohan Chauhan, Debi Bhattacharya, Felix Naughton, Wendy Hardeman, Helen Eborall, Miranda Van Emmenis, Anna De Simoni, Amrit Takhar, Pankaj Gupta, Prashanth Patel, Cecilia Mascolo, Andrew Toby Prevost, Stephen Morris, Simon Griffin, Richard J. McManus, Jonathan Mant & Stephen Sutton. (2021) The feasibility of the PAM intervention to support treatment-adherence in people with hypertension in primary care: a randomised clinical controlled trial. Scientific Reports 11:1.
Crossref
Crossref
Aikaterini Kassavou, Venus Mirzaei, James Brimicombe, Simon Edwards, Efthalia Massou, A Toby Prevost, Simon Griffin & Stephen Sutton. (2020) A Highly Tailored Text and Voice Messaging Intervention to Improve Medication Adherence in Patients With Either or Both Hypertension and Type 2 Diabetes in a UK Primary Care Setting: Feasibility Randomized Controlled Trial of Clinical Effectiveness. Journal of Medical Internet Research 22:5, pages e16629.
Crossref
Crossref
Michel BurnierBrent M. Egan. (2019) Adherence in Hypertension. Circulation Research 124:7, pages 1124-1140.
Crossref
Crossref
Jinkwon KimCheryl D. BushnellHye Sun LeeSang Won Han. (2018) Effect of Adherence to Antihypertensive Medication on the Long-Term Outcome After Hemorrhagic Stroke in Korea. Hypertension 72:2, pages 391-398.
Crossref
Crossref
Amy Chan & Rob Horne. 2018. Drug Adherence in Hypertension and Cardiovascular Protection. Drug Adherence in Hypertension and Cardiovascular Protection
123
141
.
Francesco Vittorio Costa. (2017) Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment. High Blood Pressure & Cardiovascular Prevention 24:3, pages 265-274.
Crossref
Crossref
Antonio Coca, Enrico Agabiti-Rosei, Renata Cifkova, Athanasios J. Manolis, Josep Redón & Giuseppe Mancia. (2017) The polypill in cardiovascular prevention. Journal of Hypertension 35:8, pages 1546-1553.
Crossref
Crossref
F F Alharbi, P C Souverein, M C de Groot, A H Maitland-van der Zee, A de Boer & O H Klungel. (2017) Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case–control study. Journal of Human Hypertension 31:8, pages 537-544.
Crossref
Crossref
Tao Xu, Xinyuan Yu, Shu Ou, Xi Liu, Jinxian Yuan, Xinjie Tan & Yangmei Chen. (2017) Adherence to Antihypertensive Medications and Stroke Risk: A Dose‐Response Meta‐Analysis. Journal of the American Heart Association 6:7.
Crossref
Crossref
Giovanni Corrao, Federico Rea, Matteo Monzio Compagnoni, Luca Merlino & Giuseppe Mancia. (2017) Protective effects of antihypertensive treatment in patients aged 85 years or older. Journal of Hypertension 35:7, pages 1432-1441.
Crossref
Crossref
Ondřej Ludka. (2017) Patient motivation for lifelong use of antihypertensive medication. Medicína pro praxi 14:1, pages 11-14.
Crossref
Crossref
Thi-Phuong-Lan Nguyen, Catharina C. M. Schuiling-Veninga, Thi Bach Yen Nguyen, Thu-Hang Vu, E. Pamela Wright & Maarten J. Postma. (2017) Adherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community. PLOS ONE 12:2, pages e0171203.
Crossref
Crossref
Yun Jung Choi, Young‐Mi Ah, Jisun Kong, Kyung Hee Choi, Baegeum Kim, Nayoung Han, Yun Mi Yu, Jung Mi Oh, Wan Gyoon Shin, Hae‐Young Lee & Ju‐Yeun Lee. (2016) Implication of different initial beta blockers on treatment persistence: atenolol vs new‐generation beta blocker, a population‐based study. Cardiovascular Therapeutics 34:4, pages 268-275.
Crossref
Crossref
Tzahit Simon-Tuval, Noa Triki, Gabriel Chodick & Dan Greenberg. (2015) The association between adherence to cardiovascular medications and healthcare utilization. The European Journal of Health Economics 17:5, pages 603-610.
Crossref
Crossref
Julie C. Will, Zefeng Zhang, Matthew D. Ritchey & Fleetwood Loustalot. (2016) Medication Adherence and Incident Preventable Hospitalizations for Hypertension. American Journal of Preventive Medicine 50:4, pages 489-499.
Crossref
Crossref
Giovanni CorraoFederico ReaArianna GhirardiDavide SorannaLuca MerlinoGiuseppe Mancia. (2015) Adherence With Antihypertensive Drug Therapy and the Risk of Heart Failure in Clinical Practice. Hypertension 66:4, pages 742-749.
Crossref
Crossref
Elvira O. Gosmanova & Csaba P. Kovesdy. (2015) Adherence to antihypertensive medications: is prescribing the right pill enough?. Nephrology Dialysis Transplantation 30:10, pages 1649-1656.
Crossref
Crossref
Elvira O. GosmanovaJun L. LuElani StrejaWilliam C. CushmanKamyar Kalantar-ZadehCsaba P. Kovesdy. (2014) Association of Medical Treatment Nonadherence With All-Cause Mortality in Newly Treated Hypertensive US Veterans. Hypertension 64:5, pages 951-957.
Crossref
Crossref
Giuseppe Mancia, Antonella Zambon, Davide Soranna, Luca Merlino & Giovanni Corrao. (2014) Factors involved in the discontinuation of antihypertensive drug therapy. Journal of Hypertension 32:8, pages 1708-1716.
Crossref
Crossref
M.H.D. Wasem Alsabbagh, Mark Lemstra, Dean Eurich, Lisa M. Lix, Thomas W. Wilson, Erin Watson & David F. Blackburn. (2014) Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis. Value in Health 17:2, pages 288-296.
Crossref
Crossref
Roland E. Schmieder, Massimo Volpe, Bernard Waeber & Luis M. Ruilope. (2014) A guide for easy- and difficult-to-treat hypertension. International Journal of Cardiology 172:1, pages 17-22.
Crossref
Crossref
F. Midy & A. Rudnichi. (2013) The impact of cardiovascular profile on persistence associated with antihypertensive medications. International Journal of Clinical Practice 67:12, pages 1334-1341.
Crossref
Crossref
Carla Koopman, Ilonca Vaartjes, Edith M. Heintjes, Wilko Spiering, Ineke van Dis, Ron M.C. Herings & Michiel L. Bots. (2013) Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010. European Heart Journal 34:41, pages 3198-3205.
Crossref
Crossref
Sukyoun Shin, Hyunjong Song, Sang-Kwon Oh, Kyung Eob Choi, Ho Kim & Sunmee Jang. (2013) Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertension Research 36:11, pages 1000-1005.
Crossref
Crossref
Martin C.S. Wong, Wilson W.S. Tam, Clement S.K. Cheung, Harry H.X. Wang, Ellen L.H. Tong, Antonio C.H. Sek, Bryan P.Y. Yan, N.T. Cheung, Stephen Leeder, C.M. Yu & Sian Griffiths. (2013) Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: A five-year cohort study. International Journal of Cardiology 168:2, pages 928-933.
Crossref
Crossref
Asaf Bitton, Niteesh K. Choudhry, Olga S. Matlin, Kellie Swanton & William H. Shrank. (2013) The Impact of Medication Adherence on Coronary Artery Disease Costs and Outcomes: A Systematic Review. The American Journal of Medicine 126:4, pages 357.e7-357.e27.
Crossref
Crossref
C. D. Evans, D. T. Eurich, X. Lu, A. J. Remillard, Y. M. Shevchuk & D. Blackburn. (2012) The Association Between Market Availability and Adherence to Antihypertensive Medications: An Observational Study. American Journal of Hypertension 26:2, pages 180-190.
Crossref
Crossref
Randi Selmer, Hege Salvesen Blix, Knud Landmark & Åsmund Reikvam. (2012) Choice of initial antihypertensive drugs and persistence of drug use—a 4-year follow-up of 78,453 incident users. European Journal of Clinical Pharmacology 68:10, pages 1435-1442.
Crossref
Crossref
Sayed H. Naderi, Jonathan P. Bestwick & David S. Wald. (2012) Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients. The American Journal of Medicine 125:9, pages 882-887.e1.
Crossref
Crossref
Rainer Düsing, Patrick Brunel, InYoung Baek & Fabio Baschiera. (2012) Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan. Journal of Hypertension 30:5, pages 1029-1040.
Crossref
Crossref
Sigrid Mennickent, M. Vega, H. Vega, Marta Diego & Ricardo Fierro. (2012) Quantitative determination of propranolol in human serum by high-performance thin-layer chromatography. Journal of Planar Chromatography – Modern TLC 25:1, pages 54-59.
Crossref
Crossref
Giovanni CorraoFederica NicotraAndrea ParodiAntonella ZambonFranca HeimanLuca MerlinoIda FortinoGiancarlo CesanaGiuseppe Mancia. (2011) Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice. Hypertension 58:4, pages 566-572.
Crossref
Crossref
Jian-Guang Yu, Rui-Rui Zhou & Guo-Jun Cai. (2011) From Hypertension to Stroke: Mechanisms and Potential Prevention Strategies. CNS Neuroscience & Therapeutics 17:5, pages 577-584.
Crossref
Crossref
Robert Petrella & Paul Michailidis. (2011) Retrospective Analysis of Real-World Efficacy of Angiotensin Receptor Blockers Versus Other Classes of Antihypertensive Agents in Blood Pressure Management. Clinical Therapeutics 33:9, pages 1190-1203.
Crossref
Crossref
C. Piñol, E. Alegría & S. Langham. (2011) Carga epidemiológica y económica de la hipertensión arterial en pacientes con síndrome metabólico en España: un modelo basado en la prevalencia. Hipertensión y Riesgo Vascular 28:4, pages 126-136.
Crossref
Crossref
Eberhard Wille, Jürgen Scholze, Eduardo Alegria, Claudio Ferri, Sue Langham, Warren Stevens, David Jeffries & Kerstin Uhl-Hochgraeber. (2010) Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy. The European Journal of Health Economics 12:3, pages 205-218.
Crossref
Crossref
Giuseppe Mancia, Andrea Parodi, Luca Merlino & Giovanni Corrao. (2011) Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class. Journal of Hypertension 29:5, pages 1012-1018.
Crossref
Crossref
Giovanni Corrao, Andrea Parodi, Federica Nicotra, Antonella Zambon, Luca Merlino, Giancarlo Cesana & Giuseppe Mancia. (2011) Better compliance to antihypertensive medications reduces cardiovascular risk. Journal of Hypertension 29:3, pages 610-618.
Crossref
Crossref
Jürgen Scholze, Eduardo Alegria, Claudio Ferri, Sue Langham, Warren Stevens, David Jeffries & Kerstin Uhl-Hochgraeber. (2010) Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health 10:1.
Crossref
Crossref
Atholl Johnston, Panagiotis Stafylas & George S. Stergiou. (2010) Effectiveness, safety and cost of drug substitution in hypertension. British Journal of Clinical Pharmacology 70:3, pages 320-334.
Crossref
Crossref
Peter M Rothwell. (2010) Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. The Lancet 375:9718, pages 938-948.
Crossref
Crossref
W.J. Elliott. (2010) Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients. Yearbook of Cardiology 2010, pages 41-43.
Crossref
Crossref
W.J. Elliott. (2010) Differential risks of stroke in pharmacotherapy on uncomplicated hypertensive patients?. Yearbook of Cardiology 2010, pages 43-45.
Crossref
Crossref
Francesco Vittorio Costa, Luca Degli Esposti, Carlo Cerra, Chiara Veronesi & Stefano Buda. (2009) Trends in Prescription and Determinants of Persistence to Antihypertensive Therapy. High Blood Pressure & Cardiovascular Prevention 16:4, pages 167-176.
Crossref
Crossref
Colleen A. McHorney, C. Victor Spain, Charles M. Alexander & Jeffrey Simmons. (2009) Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims. Clinical Therapeutics 31:11, pages 2584-2607.
Crossref
Crossref
Giampiero MazzagliaEttore AmbrosioniMarianna AlacquaAlessandro FilippiEmiliano SessaVincenzo ImmordinoClaudio BorghiOvidio BrignoliAchille P. CaputiClaudio CricelliLorenzo G. Mantovani. (2009) Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients. Circulation 120:16, pages 1598-1605.
Crossref
Crossref
William J. Elliott. (2009) Improving Outcomes in Hypertensive Patients: Focus on Adherence and Persistence With Antihypertensive Therapy. The Journal of Clinical Hypertension 11:7, pages 376-382.
Crossref
Crossref
M. Burnier, R. E. Brown, S. H. Ong, A. Keskinaslan & Z. M. Khan. (2009) Issues in blood pressure control and the potential role of single-pill combination therapies. International Journal of Clinical Practice 63:5, pages 790-798.
Crossref
Crossref